Canine Subcutaneous Mast Cell Tumour: Diagnosis and Prognosis

Journal of Comparative Pathology

Volumn 136, Issue 4, 2007, Pages 231-239

  Newman, S J ^a   Mrkonjich, L ^a   Walker, K K ^a   Rohrbach, B W ^b  

^a Department of Pathobiology ^*

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

dog; immunohistochemistry; mast cell tumour

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLINE; KI 67 ANTIGEN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER GRADING; CELL LABELING; CHROMOSOME NOR; CONTROLLED STUDY; CORRELATION ANALYSIS; DOG DISEASE; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MAST CELL; METASTASIS; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SCORING SYSTEM; SILVER STAINING; SKIN SURGERY; SUBCUTANEOUS TISSUE TUMOR; SURVIVAL RATE; SURVIVAL TIME; TUMOR CELL; UNITED STATES; VETERINARY MEDICINE;

ANIMALS; DOGS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MASTOCYTOSIS, CUTANEOUS; NEOPLASM STAGING; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; SKIN NEOPLASMS;

CANIS FAMILIARIS;

EID: 34247874768     PISSN: 00219975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcpa.2007.02.003     Document Type: Article

References (27)

1. Abadie J.J., Amardeilh M.A., and Delverdier M.E. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs. Journal of the American Veterinary Medical Association 215 (1999) 1629-1634
2. Al-Sarraf R., Mauldin G.N., Patnaik A.K., and Meleo K.A. A prospective study of radiation therapy for the treatment of grade 2 mast cell tumors in 32 dogs. Journal of Veterinary Internal Medicine 10 (1996) 376-378
3. Bostock D.E. The prognosis following surgical removal of mastocytomas in dogs. Journal of Small Animal Practice 14 (1973) 27-40
4. Bostock D.E., Crocker J., Harris K., and Smith P. Nucleolar organizer regions as indicators of post-surgical prognosis in canine spontaneous mast cell tumors. British Journal of Cancer 59 (1989) 915-918
5. Frimberger A.E., Moore A.S., LaRue S.M., Gliatto J.M., and Bengtson A.E. Radiotherapy of incompletely resected, moderately differentiated mast cell tumors in the dog: 37 cases (1989-1993). Journal of the American Animal Hospital Association 33 (1997) 320-324
6. Ginn P.E., Fox L.E., Brower J.C., Gaskin A., Kurzman I.D., and Kubilis P.S. Immunohistochemical detection of p53 tumor-suppressor protein is a poor indicator of prognosis for canine cutaneous mast cell tumors. Veterinary Pathology 37 (2000) 33-39
7. Hung L.C., Pong V.F., Cheng C.R., Wong F.I., and Chu R.M. An improved system for quantifying AgNOR and PCNA in canine tumors. Anticancer Research 20 (2000) 3273-3280
8. Jaffe M.H., Hosgood G., Taylor H.W., Kerwin S.C., Hedlund C.S., Lopez M.K., Davidson J.R., Miller D.M., and Paranjpe M. Immunohistochemical and clinical evaluation of p53 in canine cutaneous mast cell tumor. Veterinary Pathology 37 (2000) 40-46
9. Kiupel M., Webster J.D., Kaneene J.B., Kaneene R., and Yuzbasiyan-Gurkan V. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors. Veterinary Pathology 41 (2004) 371-377
10. Ladue T., Price G.S., Dodge R., Page R.L., and Thrall D.E. Radiation therapy for incompletely resected canine mast cell tumors. Veterinary Radiology and Ultrasound 39 (1998) 57-62
11. Leibman N.F., Lana S.E., Hansen R.A., Powers B.E., Fettman M.J., Withrow S.J., and Ogilvie G.K. Identification of matrix metalloproteinases in canine cutaneous mast cell tumors. Journal of Veterinary Internal Medicine 14 (2000) 583-586
12. London C.A., Kisseberth W.C., Galli S.J., Geissler E.N., and Helfand S.C. Expression of stem cell factor receptor (c-Kit) by the malignant mast cells from spontaneous canine mast cell tumours. Journal of Comparative Pathology 115 (1996) 399-414
13. Macy D.W., and MacEwen E.G. Canine mast cell tumors. In: Withrow S.J., and MacEwen E.G. (Eds). Clinical Veterinary Oncology (1989), J.B. Lippincott, Philadelphia 156-166
14. Murphy S., Sparkes A.H., Blunden A.S., Brearley M.J., and Smith K.C. Effects of stage and number of tumours on prognosis of dogs with cutaneous mast cell tumours. Veterinary Record 158 (2006) 287-291
15. Newman S.J. Diagnostic pathology for the cancer patient. Clinical Techniques in Small Animal Practice 18 (2003) 139-144
16. Patnaik A.K., Ehler W.J., and MacEwen E.G. Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Veterinary Pathology 21 (1984) 469-474
17. Powers, B.E. (2001). The pathology of neoplasia. In: Small Animal Clinical Oncology, 3rd Edit., S. J. Withrow and E. G. MacEwen, Eds., W.B. Saunders, Philadelphia, pp 4-17.
18. Preziosi R., Morini M., and Sarli G. Expression of the KIT protein (CD117) in primary cutaneous mast cell tumors of the dog. Journal of Veterinary Diagnostic Investigation 16 (2004) 554-561
19. Reguera M.J., Rabanal R.M., Puigdemont A., and Ferrer L. Canine mast cell tumors express stem cell factor receptor. American Journal of Dermatopathology 22 (2000) 49-54
20. Sakai H., Noda A., Shirai N., Iidaka T., Yanai T., and Masegi T. Proliferative activity of canine mast cell tumours evaluated by bromodeoxyuridine incorporation and Ki67 expression. Journal of Comparative Pathology 127 (2002) 233-238
21. Seguin B., Leibman N.F., Bregazzi V.S., Ogilvie G.K., Powers B.E., Dernell W.S., Fettman M.J., and Withrow S.J. Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996-1999). Journal of the American Veterinary Medical Association 218 (2001) 1120-1123
22. Simoes J.P.C., and Schoning P. Canine mast cell tumors: a comparison of staining techniques. Journal of Veterinary Diagnostic Investigation 6 (1994) 458-465
23. Simpson A.M., Ludwig L.L., Newman S.J., Bergman P.J., Hottinger H.A., and Patnaik A.K. Evaluation of surgical margins required for complete excision of cutaneous mast cell tumors in dogs. Journal of the American Veterinary Medical Association 224 (2004) 236-240
24. Thamm, D.H. and Vail, D.M. (2001). Mast cell tumor. In: Small Animal Clinical Oncology, 3rd Edit., S. J. Withrow and E. G. MacEwen, Eds, W.B. Saunders, Philadelphia, pp. 261-282.
25. Weisse C., Shofer F.S., and Sorenmo K. Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision. Journal of the American Animal Hospital Association 38 (2002) 71-73
26. Wu H., Hayashi T., and Inoue M. Immunohistochemical expression of p27 and p21 in canine cutaneous mast cell tumors and histiocytomas. Veterinary Pathology 41 (2004) 296-299
27. Zemke D., Yamini B., and Yuzbasiyan-Gurkin V. Characterization of an undifferentiated malignancy as a mast cell tumor using mutation analysis in the proto-oncogene c-KIT. Journal of Veterinary Diagnostic Investigation 13 (2001) 341-345